Acumen Research and Consulting estimates that the global eubiotics market is anticipated to reach market size of around US$ 7,000 Mn by 2027 and is expected to grow at a CAGR of around 5% in terms of revenue during the forecast period 2020 – 2027.
Eubiotics are feed additives for animals which improve feed's nutritional value and improve animal health. Naturally, eubiotics help and protect the health of the animal stomach. Organic plant extracts and carboxylic acids are ingredients used in eubiotics.
Market Insights
Growing awareness regarding benefits of agricultural products and supportive policy policies to increase feed quality is expected to fuel the growth of the eubiotic industry. Such materials are used in the feeding of diets of beef and dairy calves, chickens, ruminants and aquaculture industries. Eubiotic products help the strengthening of the immune system and the fighting capacity of bacterial or viral infections. Increased meat consumption due to high meat productivity and convenient exposure to meat products that can increase food demand, would drive the market. Product specifications, increased disposable income and changing eating habit has led the global meat industry to over US$ 40 billion in 2018. Global meat demand is projected to hit up to 323 million tonnes, with 450 million tons predicted to cross by 2030. Throughout the expected span of time, the rise in disposable income along with solid growth in the processed food and drink industry would boost the demand on the eubiotic market. Manufacturers are investing in R&D to develop tailored products, brand awareness, and rise the market share of eubiotics. The industry leaders have created new growth prospects for reasons such as advancements in molecular biology and gene sequencing. Therefore, businesses collaborate together or cooperate in the production of technologies and product releases, and form agreements or distributor agreements. However, in addition to supply chain problems and reduced demand for meat goods COVID-19 outbreaks have affected the industry. Strict regulatory guidelines on the prohibition of antibiotics growth promoter (AGP) by the FDA and the EU Commission as a result of the bioaccumulation of antibiotics and meat products in the animal gastrointestinal tract, contribute to growing demands for natural growth promoters. The future substitutes for AGPs include products such as essential oils, organic acids, prebiotics and probiotics, which offer added benefits to the development of the eubiotics industry.
The US accounts for more than half of the demand in eubiotics in North America. The Food and Drug Administration's (FDA) ban on antibiotics in the United States in 2017 and ongoing research product advancement by local and global players are main factors driving demand growth. Pork, poultry and veal are the region's most common meat consumption. However, national governing bodies follow alternate sustainable strategies to produce high-quality, effective and safe feed additives. The US is a well-known market with high appetite for organic beef, which has driven producers to use natural ingredients in animal feed. The demand for eubiotics in animal feed in the country is also expected to increase. Europe is the largest eubiotic market of which the leading countries are Germany, France and UK. Prohibition of the use of antibiotics, enhanced environmental protection issues exacerbate business gains relative to other countries. America also has an immense growth opportunity in the eubiotic sector and is the fastest developing nation. Furthermore, rising fears about animal welfare are pushing the development of eubiotics in North America, as is the ban on the use of antibiotics in animal feed. Another region of the forthcoming eubiotics sector is Asia-Pacific. The demand is being driven by fast financial growth, increasing visibility, increased consumption of meat and dairy products. This gives eubiotic producers a huge opportunity to have superior feed consistency. Lack of knowledge and costs is still a restraining factor for the eubiotic market.
Key Players
Major players included in this report are DSM, Alltech, BASF, Dupont, Cargill, Novozymes, Friesland Campina, Chr. Hansen, Lesaffre Group, Kemin Industries, Lallemand, Inc., Calpis, Friesland Campina, Novus International, and others. Throughout Asia-Pacific and in North American, the eubiotics market is concentrated and broken up into small regional players. Leading corporations concentrate on the purchase of feed mills, and independent farmers grow the sector both domestically and abroad. Many of the players expanded their global footprint in international markets by mergers with the local manufacturers.
The global eubiotics market is segmented as below:
Market Segmentation
Eubiotics Market By Type
Probiotics
Prebiotics
Organic Acids
Essential Oils
Eubiotics Market By Livestock
Poultry
Swine
Ruminants
Aquatic Animals
Eubiotics Market By Function
Nutrition & Gut Health
Yield
Immunity
Production
Eubiotics Market By Dosage Form
Dry
Liquid
Eubiotics Market By Geography
North America
Europe
- U.K
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Eubiotics
1.1. Definition and Scope
1.1.1. Definition of Eubiotics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Eubiotics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Eubiotics Market By Type
1.2.3. Eubiotics Market By Livestock
1.2.4. Eubiotics Market By Function
1.2.5. Eubiotics Market By Dosage Form
1.2.6. Eubiotics Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Regulatory Compliance
3.6. Competitive Landscape, 2019
3.6.1. Player Positioning Analysis
3.6.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Eubiotics Market By Type
4.1. Introduction
4.2. Eubiotics Revenue By Type
4.2.1. Eubiotics Revenue (US$ Mn) and Forecast, By Type, 2016-2027
4.2.2. Probiotics
4.2.2.1. Probiotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Prebiotics
4.2.3.1. Prebiotics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Organic Acids
4.2.4.1. Organic Acids Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Essential Oils
4.2.5.1. Essential Oils Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Eubiotics Market Revenue By Livestock
5.1. Introduction
5.2. Eubiotics Revenue (US$ Mn) By Livestock
5.2.1. Eubiotics Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
5.2.2. Poultry
5.2.2.1. Poultry Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Swine
5.2.3.1. Swine Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Ruminants
5.2.4.1. Ruminants Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Aquatic Animals
5.2.5.1. Aquatic Animals Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Eubiotics Market By Function
6.1. Introduction
6.2. Eubiotics Revenue (US$) By Function
6.2.1. Eubiotics Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
6.3. Nutrition & Gut Health
6.3.1. Nutrition & Gut Health Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.4. Yield
6.4.1. Yield Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.5. Immunity
6.5.1. Immunity Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.6. Production
6.6.1. Production Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Eubiotics Market By Dosage Form
7.1. Introduction
7.2. Eubiotics Revenue (US$) By Dosage Form
7.2.1. Eubiotics Revenue (US$ Mn) and Forecast By Dosage Form, 2016 - 2027
7.3. Dry
7.3.1. Dry Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.4. Liquid
7.4.1. Liquid Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Eubiotics Market By Country
8.1. North America Eubiotics Overview
8.2. U.S.
8.2.1. U.S. Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.2. U.S. Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
8.2.3. U.S. Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
8.2.4. U.S. Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
8.3. Canada
8.3.1. Canada Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.2. Canada Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
8.3.3. Canada Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
8.3.4. Canada Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Eubiotics Market By Country
9.1. Europe Eubiotics Market Overview
9.2. U.K.
9.2.1. U.K. Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.2.2. U.K. Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
9.2.3. U.K. Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
9.2.4. U.K. Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
9.3. Germany
9.3.1. Germany Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.3.2. Germany Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
9.3.3. Germany Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
9.3.4. Germany Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
9.4. France
9.4.1. France Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.4.2. France Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
9.4.3. France Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
9.4.4. France Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
9.5. Spain
9.5.1. Spain Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.5.2. Spain Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
9.5.3. Spain Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
9.5.4. Spain Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.6.2. Rest of Europe Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016-2027
9.6.3. Rest of Europe Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016-2027
9.6.4.
9.6.5. Rest of Europe Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Eubiotics Market By Country
10.1. Asia Pacific Eubiotics Market Overview
10.2. China
10.2.1. China Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2. China Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
10.2.3. China Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
10.2.4. China Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
10.3. Japan
10.3.1. Japan Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2. Japan Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
10.3.3. Japan Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
10.3.4. Japan Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
10.4. India
10.4.1. India Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2. India Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
10.4.3. India Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
10.4.4. India Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
10.5. Australia
10.5.1. Australia Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.2. Australia Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
10.5.3. Australia Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
10.5.4. Australia Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
10.6. South Korea
10.6.1. South Korea Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.2. South Korea Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
10.6.3. South Korea Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
10.6.4. South Korea Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.2. Rest of Asia-Pacific Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
10.7.3. Rest of Asia-Pacific Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
10.7.4. Rest of Asia-Pacific Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Eubiotics Market By Country
11.1. Latin America Eubiotics Market Overview
11.2. Brazil
11.2.1. Brazil Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2. Brazil Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
11.2.3. Brazil Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
11.2.4. Brazil Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
11.3. Mexico
11.3.1. Mexico Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2. Mexico Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
11.3.3. Mexico Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
11.3.4. Mexico Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2. Rest of Latin America Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
11.4.3. Rest of Latin America Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
11.4.4. Rest of Latin America Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Eubiotics Market By Country
12.1. Middle East & Africa Eubiotics Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.2. Saudi Arabia Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
12.2.3. Saudi Arabia Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
12.2.4. Saudi Arabia Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
12.3. UAE
12.3.1. UAE Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.2. UAE Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
12.3.3. UAE Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
12.3.4. UAE Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Eubiotics Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.2. Rest of Middle East & Africa Eubiotics Market Revenue (US$ Mn) and Forecast By Livestock, 2016 - 2027
12.4.3. Rest of Middle East & Africa Eubiotics Market Revenue (US$ Mn) and Forecast By Function, 2016 - 2027
12.4.4. Rest of Middle East & Africa Eubiotics Market Revenue (US$ Mn) and Forecast By Dosage Form, 2016 – 2027
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Eubiotics
13.1. Eubiotics Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Type Launches and Type Enhancements
13.2.3. Mergers And Acquisition In Global Eubiotics Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. DSM
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. DSM 2019 Eubiotics Business Regional Distribution
14.1.4. Type/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Alltech
14.3. BASF
14.4. Dupont
14.5. Cargill
14.6. Novozymes
14.7. Friesland Campina
14.8. Chr. Hansen
14.9. Lesaffre Group
14.10. Kemin Industries
14.11. Lallemand, Inc.
14.12. Calpis
14.13. Friesland Campina
14.14. Novus International
14.15. Others
